Fundraising Fox
Neurotherapia
Cleveland, US · Founded 2015 · 8 employees on LinkedIn · 2 known investors
Find your way into Neurotherapia
Sign up to see every warm intro you have to Neurotherapia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurotherapia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.
Investors · 2
Dolby Family Ventures✓ confirmed by NeurotherapiaSan Francisco
How we know: the company's own site · Dolby Family Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Neurotherapia do?
- NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.
- Who are Neurotherapia's investors?
- Neurotherapia's investors include Dolby Family Ventures, Brain Trust Accelerator Fund.
- Where is Neurotherapia headquartered?
- Neurotherapia is headquartered in Cleveland, US.